Michael R Hayden bought $181k of IONS
director at IONIS PHARMACEUTICALS INC. 5,000 shares at an average of $36.22, traded Dec 23, 2024, filed Dec 26, 2024.
Score components
- +15RoleDirector
- +12Trade size$181k at market
- +3Relative to holdingsHoldings up 17%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874015-24-000243, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | POpen-market purchase Common Stock | +2,500 | $36.20 | $90k | 32,719 | Dec 26, 2024 |
| Dec 23, 2024 | POpen-market purchase Common Stock | +2,500 | $36.23 | $91k | 35,219 | Dec 26, 2024 |
Related signals
Other insiders at IONIS PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IONIS PHARMACEUTICALS INC | Joseph H Wender director | $2.3M 28,000 shares | -44% | |
| 30Weak | IONIS PHARMACEUTICALS INC | Shannon L. Devers EVP, Chief Human Resources Ofc | $1.4M 16,777 shares | -49% | |
| 39Weak | IONIS PHARMACEUTICALS INC | Joseph Klein III director | $960k 12,000 shares | -300% | |
| 60Notable | IONIS PHARMACEUTICALS INC | Joan E Herman director | $3.2M 44,000 shares | -76% | |
| 35Weak | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $609k 8,000 shares | -14% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Richard S Geary EVP, Chief Development Officer | $2.6M 34,639 shares | -57% | |
| 6Weak | IONIS PHARMACEUTICALS INC | Richard S Geary EVP, Chief Development Officer | $126k 1,680 shares | -3% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Richard S Geary EVP, Chief Development Officer | $6.8M 90,929 shares | -80% | |
| 30Weak | IONIS PHARMACEUTICALS INC | Joseph Loscalzo director | $1.2M 16,000 shares | -31% | |
| 45Moderate | IONIS PHARMACEUTICALS INC | Joseph H Wender director | $2.1M 28,000 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.